Activist 13D/13G Filings - ARCH Venture Fund VIII L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-05-13
5:34 pm
Unchanged
13GQ32 BIO INC
QTTB
ARCH Venture Fund VIII L.P.0
0.000%
0
(Unchanged)
View
2024-02-14
3:17 pm
Sale
13GScholar Rock Holding Corp
SRRK
ARCH Venture Fund VIII L.P.0
0.000%
-2,637,617decrease
(Position Closed)
View
2022-09-20
4:57 pm
Purchase
13DCodiak BioSciences Inc.
CDAK
ARCH Venture Fund VIII L.P.8,854,098
24.700%
5,000,000increase
(+129.73%)
View
2022-02-08
3:04 pm
Sale
13GDenali Therapeutics Inc.
DNLI
ARCH Venture Fund VIII L.P.0
0.000%
-10,735,948decrease
(Position Closed)
View
2021-02-04
5:11 pm
Purchase
13GCodiak BioSciences Inc.
CDAK
ARCH Venture Fund VIII L.P.3,854,098
20.500%
3,854,098increase
(New Position)
View
2021-02-02
5:04 pm
Purchase
13GMETACRINE INC
MTCR
ARCH Venture Fund VIII L.P.2,940,503
11.300%
2,940,503increase
(New Position)
View
2021-02-02
5:04 pm
Purchase
13GDenali Therapeutics Inc.
DNLI
ARCH Venture Fund VIII L.P.10,735,948
9.000%
37,339increase
(+0.35%)
View
2020-02-13
4:53 pm
Unchanged
13GScholar Rock Holding Corp
SRRK
ARCH Venture Fund VIII L.P.2,637,617
8.900%
0
(Unchanged)
View
2020-02-13
4:52 pm
Sale
13GDenali Therapeutics Inc.
DNLI
ARCH Venture Fund VIII L.P.10,698,609
11.100%
-370,140decrease
(-3.34%)
View
2020-02-13
4:51 pm
Sale
13GQ32 BIO INC
QTTB
ARCH Venture Fund VIII L.P.5,769,918
13.100%
-298,777decrease
(-4.92%)
View